FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry, namely to using ipidacrine as an agent for treating disturbed potency.
EFFECT: pharmaceutical composition of ipidacrine represents a tablet, including a prolonged action tablet, or a solid gel capsule.
4 cl, 4 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATMENT OF MEN WITH SEXUAL DYSFUNCTION | 2000 |
|
RU2163805C1 |
PHARMACEUTICAL COMPOSITIONS OF IPIDACRINE AND USING THEM FOR TREATING AND PREVENTING SOLUTION OF CONTINUITY | 2012 |
|
RU2512743C1 |
USE OF 3-ALPHA-ANDROSTENDIOL OPTIONALLY IN COMBINATION WITH PHOSPHODIESTERASE-5 INHIBITOR IN TREATING SEXUAL DYSFUNCTION | 2007 |
|
RU2464027C2 |
AGENT FOR TREATMENT OF MEN WITH SEXUAL DYSFUNCTION | 1999 |
|
RU2163806C1 |
MEDICATION FOR PREVENTION AND TREATMENT OF ANDROLOGICAL DISEASES AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2519226C1 |
PEPTIDE COMPOUND, STIMULATING FUNCTION OF REPRODUCTIVE SYSTEM, PHARMACEUTICAL COMPOSITION AND METHOD OF APPLICATION | 2006 |
|
RU2324703C1 |
USING 3-ANDROSTANEDIOL OPTIONALLY IN COMBINATION WITH 5-HT1A ANTAGONIST FOR TREATING SEXUAL DYSFUNCTION | 2007 |
|
RU2491073C2 |
USE OF OXATHRIAZOLO-5-OLATE FOR TREATING SEXUAL DISORDERS | 2014 |
|
RU2600845C2 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
METHOD OF SIMULATING EJACULATION OF ANIMALS | 0 |
|
SU1504663A1 |
Authors
Dates
2013-10-10—Published
2012-08-20—Filed